UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE

UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE

Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogrel) use in patients having appropriate indications according to current clinical guidelines and to study the possibility of prescription rate improvement by education activity directed to doctors. Materia...

ver descrição completa

Detalhes bibliográficos
Main Authors: S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
Formato: Artigo
Idioma:English
Publicado em: Столичная издательская компания 2015-12-01
Colecção:Рациональная фармакотерапия в кардиологии
Assuntos:
antiplatelet agents
clopidogrel
original drug
generic
dual antiplatelet therapy
Acesso em linha:https://www.rpcardio.online/jour/article/view/540

Internet

https://www.rpcardio.online/jour/article/view/540

Registos relacionados